|
Volume 272, Number 16,
Issue of April 18, 1997
pp. 10457-10463
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Differential Phosphorylation of Chicken Progesterone Receptor in
Hormone-dependent and Ligand-independent Activation
(Received for publication, January 16, 1997)
Wenlong
Bai
,
Brian G.
Rowan
,
Victoria E.
Allgood
,
Bert W.
O'Malley
and
Nancy L.
Weigel
From the Department of Cell Biology, Baylor College of Medicine,
Houston, Texas 77030
Many steroid receptors, including chicken
progesterone receptor, have been shown to be activated in the absence
of their cognate ligands by modulators of kinases and phosphatases. To
investigate the molecular mechanism of ligand-independent activation,
chicken progesterone receptor mutants in which either one or all four of the previously identified phosphorylation sites have been changed to
nonphosphorylatable alanine were analyzed for their ability to be
activated by progesterone, 8-bromoadenosine 3 :5 -cyclic monophosphate,
or a dopamine agonist, SKF82958. Our current study shows that the
receptor is differently phosphorylated in ligand-dependent and ligand-independent activation. The transcriptional activity of the
receptor in response to 8-bromoadenosine 3 :5 -cyclic monophosphate is
affected by mutation of either Ser211 or
Ser260. In addition, our data demonstrated that none of the
four sites is absolutely required for the activation of the receptor by
either 8-bromoadenosine 3 :5 -cyclic monophosphate or the dopamine
agonist. Treatment with 8-bromoadenosine 3 :5 -cyclic monophosphate did not increase the overall level of receptor phosphorylation or cause
phosphorylation of the receptor at alternate sites. These data raise
the possibility that ligand-independent activation of the chicken
progesterone receptor may be mediated through changes in the
phosphorylation of coregulators or other protein factors interacting
with the receptors.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Gordon, J. C Garrido-Gracia, R. Aguilar, S. Guil-Luna, Y. Millan, J. M. de las Mulas, and J. E Sanchez-Criado
Ovarian stimulation with FSH reduces phosphorylation of gonadotrope progesterone receptor and LH secretion in the rat
Reproduction,
January 1, 2009;
137(1):
151 - 159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E Sanchez-Criado, J. C Garrido-Gracia, C. Bellido, R. Aguilar, P. Guelmes, P. Abreu, R. Alonso, I. Barranco, Y. Millan, and J. M. de las Mulas
Oestradiol-17{beta} inhibits tamoxifen-induced LHRH self-priming blocking hormone-dependent and ligand-independent activation of the gonadotrope progesterone receptor in the rat.
J. Endocrinol.,
July 1, 2006;
190(1):
73 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Mani, A. M. Reyna, J. Z. Chen, B. Mulac-Jericevic, and O. M. Conneely
Differential Response of Progesterone Receptor Isoforms in Hormone-Dependent and -Independent Facilitation of Female Sexual Receptivity
Mol. Endocrinol.,
June 1, 2006;
20(6):
1322 - 1332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Jacobsen, S. A. Schittone, J. K. Richer, and K. B. Horwitz
Progesterone-Independent Effects of Human Progesterone Receptors (PRs) in Estrogen Receptor-Positive Breast Cancer: PR Isoform-Specific Gene Regulation and Tumor Biology
Mol. Endocrinol.,
March 1, 2005;
19(3):
574 - 587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Zou
Impacts of Xenobiotics on Crustacean Molting: The Invisible Endocrine Disruption
Integr. Comp. Biol.,
January 1, 2005;
45(1):
33 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Blaustein
Minireview: Neuronal Steroid Hormone Receptors: They're Not Just for Hormones Anymore
Endocrinology,
March 1, 2004;
145(3):
1075 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Coleman, M. Dutertre, A. El-Gharbawy, B. G. Rowan, N. L. Weigel, and C. L. Smith
Mechanistic Differences in the Activation of Estrogen Receptor-alpha (ERalpha )- and ERbeta -dependent Gene Expression by cAMP Signaling Pathway(s)
J. Biol. Chem.,
April 4, 2003;
278(15):
12834 - 12845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Labriola, M. Salatino, C. J. Proietti, A. Pecci, O. A. Coso, A. R. Kornblihtt, E. H. Charreau, and P. V. Elizalde
Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells
Mol. Cell. Biol.,
February 1, 2003;
23(3):
1095 - 1111.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. M. Jacobsen, J. K. Richer, S. A. Schittone, and K. B. Horwitz
New Human Breast Cancer Cells to Study Progesterone Receptor Isoform Ratio Effects and Ligand-independent Gene Regulation
J. Biol. Chem.,
July 26, 2002;
277(31):
27793 - 27800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Rowan, N. Garrison, N. L. Weigel, and B. W. O'Malley
8-Bromo-Cyclic AMP Induces Phosphorylation of Two Sites in SRC-1 That Facilitate Ligand-Independent Activation of the Chicken Progesterone Receptor and Are Critical for Functional Cooperation between SRC-1 and CREB Binding Protein
Mol. Cell. Biol.,
December 1, 2000;
20(23):
8720 - 8730.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S.-H. Hong and M. L. Privalsky
The SMRT Corepressor Is Regulated by a MEK-1 Kinase Pathway: Inhibition of Corepressor Function Is Associated with SMRT Phosphorylation and Nuclear Export
Mol. Cell. Biol.,
September 1, 2000;
20(17):
6612 - 6625.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. L. Smith, R. G. Wolford, T. B. ONeill, and G. L. Hager
Characterization of Transiently and Constitutively Expressed Progesterone Receptors: Evidence for Two Functional States
Mol. Endocrinol.,
July 1, 2000;
14(7):
956 - 971.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. A. Heinlein, H.-J. Ting, S. Yeh, and C. Chang
Identification of ARA70 as a Ligand-enhanced Coactivator for the Peroxisome Proliferator-activated Receptor gamma
J. Biol. Chem.,
June 4, 1999;
274(23):
16147 - 16152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-M. Moilanen, U. Karvonen, H. Poukka, O. A. Jänne, and J. J. Palvimo
Activation of Androgen Receptor Function by a Novel Nuclear Protein Kinase
Mol. Biol. Cell,
September 1, 1998;
9(9):
2527 - 2543.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S.-H. Hong, C.-W. Wong, and M. L. Privalsky
Signaling by Tyrosine Kinases Negatively Regulates the Interaction between Transcription Factors and SMRT (Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor) Corepressor
Mol. Endocrinol.,
August 1, 1998;
12(8):
1161 - 1171.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. N. Lopez, C. W. Turck, F. Schaufele, M. R. Stallcup, and P. J. Kushner
Growth Factors Signal to Steroid Receptors through Mitogen-activated Protein Kinase Regulation of p160 Coactivator Activity
J. Biol. Chem.,
June 15, 2001;
276(25):
22177 - 22182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Walters, M. Dutertre, and C. L. Smith
SKF-82958 Is a Subtype-selective Estrogen Receptor-alpha (ERalpha ) Agonist That Induces Functional Interactions between ERalpha and AP-1
J. Biol. Chem.,
January 11, 2002;
277(3):
1669 - 1679.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|